ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHA:600479)
China · Delayed Price · Currency is CNY 10.54
+0.06 (0.57%)
Feb 4, 2026, 1:22 PM CST
SHA:600479 Revenue
ZhuZhou QianJin Pharmaceutical Co.,Ltd had revenue of 900.34M CNY in the quarter ending September 30, 2025, with 13.91% growth. This brings the company's revenue in the last twelve months to 3.63B, down -2.70% year-over-year. In the year 2024, ZhuZhou QianJin Pharmaceutical Co.,Ltd had annual revenue of 3.63B, down -4.44%.
Revenue (ttm)
3.63B
Revenue Growth
-2.70%
P/S Ratio
1.42
Revenue / Employee
689.47K
Employees
5,270
Market Cap
5.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.63B | -168.68M | -4.44% |
| Dec 31, 2023 | 3.80B | -227.79M | -5.66% |
| Dec 31, 2022 | 4.03B | 362.43M | 9.89% |
| Dec 31, 2021 | 3.66B | 36.88M | 1.02% |
| Dec 31, 2020 | 3.63B | 101.73M | 2.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jianmin Pharmaceutical Group | 3.18B |
| Jiangsu Lianhuan Pharmaceutical | 2.60B |
| Luoxin Pharmaceuticals Group Stock | 2.49B |
| Fuan Pharmaceutical (Group) | 1.71B |
| Hunan Fangsheng Pharmaceutical | 1.68B |
| Bide Pharmatech | 1.27B |
| Nanjing Hicin Pharmaceutical | 615.39M |
| Zhongzhu Healthcare Holding Co.,Ltd | 570.62M |